74 related articles for article (PubMed ID: 10635646)
1. [Spectrum of apolipoproteins of blood serum in patients with non- insulin-dependent diabetes mellitus on acarbose treatment].
Rosliakova LV; Roĭtman AP; Rakov SS; Ametov AS; Dolgov VV
Klin Med (Mosk); 1999; 77(10):15-7. PubMed ID: 10635646
[No Abstract] [Full Text] [Related]
2. Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes.
Wagner H; Degerblad M; Thorell A; Nygren J; Ståhle A; Kuhl J; Brismar TB; Ohrvik J; Efendic S; Båvenholm PN
Diabetes Care; 2006 Jul; 29(7):1471-7. PubMed ID: 16801564
[TBL] [Abstract][Full Text] [Related]
3. Effect of acarbose on postmeal mononuclear blood cell response in patients with early type 2 diabetes: the AI(I)DA study.
Hanefeld M; Schaper F; Koehler C; Bergmann S; Ugocsai P; Stelzer J; Schmitz G
Horm Metab Res; 2009 Feb; 41(2):132-6. PubMed ID: 19214923
[TBL] [Abstract][Full Text] [Related]
4. [Changes in metabolic parameters and microalbuminuria in patients with type 2 diabetes treated with acarbose].
González Sarmiento E; Ergueta Martín P; Fernández Martínez I; Hinojosa Mena-Bernal MC; Zurro Muñoz I; Zurro Hernández J
An Med Interna; 2001 May; 18(5):234-6. PubMed ID: 11496556
[TBL] [Abstract][Full Text] [Related]
5. [Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?].
Leschke M
Med Klin (Munich); 2003 Oct; 98 Suppl 1():12-6. PubMed ID: 14694836
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of acarbose in type 2 diabetes mellitus in Jamaica.
Morrison EY; Wright-Pascoe R; Aquart A; Robinson H; Banbury M; Whitbourne F; Callender J; Less L; Bailey S
West Indian Med J; 2000 Dec; 49(4):285-9. PubMed ID: 11211536
[TBL] [Abstract][Full Text] [Related]
7. Acarbose reduces the risk of pre-lunch hypoglycemia in elderly people with diabetes eating rice porridge for breakfast.
Hsieh CJ
Diabetes Res Clin Pract; 2010 Sep; 89(3):e66-8. PubMed ID: 20619914
[TBL] [Abstract][Full Text] [Related]
8. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
Kirkman MS; Shankar RR; Shankar S; Shen C; Brizendine E; Baron A; McGill J
Diabetes Care; 2006 Sep; 29(9):2095-101. PubMed ID: 16936159
[TBL] [Abstract][Full Text] [Related]
9. [Cardioprotection by acarbose--pro].
Breuer HW
Dtsch Med Wochenschr; 2004 May; 129(20):1155. PubMed ID: 15143459
[No Abstract] [Full Text] [Related]
10. [Acarbose in the treatment of type 2 diabetes].
Amoretti R; Cicconetti C; De Nichilo M; Teodonio C; Fasani R; Carosi M
Minerva Dietol Gastroenterol; 1986; 32(1):53-9. PubMed ID: 3517699
[No Abstract] [Full Text] [Related]
11. Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes.
Abbink EJ; Pickkers P; van Rosendaal AJ; Lutterman JA; Tack CJ; Russel FG; Smits P
Clin Sci (Lond); 2002 Mar; 102(3):307-14. PubMed ID: 11869171
[TBL] [Abstract][Full Text] [Related]
12. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
Laakso M
Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
[No Abstract] [Full Text] [Related]
13. [Drug therapy of type 2 diabetes: insulin sensitizers improve results].
Stadler HJ
Pflege Z; 1999 Nov; 52(11):772-5. PubMed ID: 10788929
[No Abstract] [Full Text] [Related]
14. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
Zeymer U
Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
[TBL] [Abstract][Full Text] [Related]
15. [Cardioprotection by acarbose--contra].
Kaiser T; Sawicki PT
Dtsch Med Wochenschr; 2004 May; 129(20):1156. PubMed ID: 15143460
[No Abstract] [Full Text] [Related]
16. [Acarbose (glucobai) effects on lipid metabolism in patients with non-insulin dependent diabetes mellitus].
Rosliakova LV; Roĭtman AP; Ametov AS; Dolgov VV
Ter Arkh; 2000; 72(8):54-6. PubMed ID: 11019430
[TBL] [Abstract][Full Text] [Related]
17. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
Rosak C; Hofmann U; Paulwitz O
Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
[TBL] [Abstract][Full Text] [Related]
18. Drugs for diabetes.
Abramowicz M; Zuccotti G;
Treat Guidel Med Lett; 2005 Aug; 3(36):57-62. PubMed ID: 16012392
[No Abstract] [Full Text] [Related]
19. Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting.
Roze S; Valentine WJ; Evers T; Palmer AJ
Curr Med Res Opin; 2006 Jul; 22(7):1415-24. PubMed ID: 16834840
[TBL] [Abstract][Full Text] [Related]
20. [Robert Koch Award for acarbose. Antidiabetic drug prevents myocardial infarct].
MMW Fortschr Med; 2003 Feb; 145(6):59. PubMed ID: 12619367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
